Meetings and Conferences.
- Published in:
- 2017
- Publication type:
- Calendar
Works matching IS 16613791 AND DT 2017 AND VI 12 AND IP 3
Results: 16
1
2
First-Line-Therapie mit Bevacizumab – Standard beim fortgeschrittenen Ovarialkarzinom.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 198
- Publication type:
- Article
3
Cinfa Biotech veröffentlicht positive Ergebnisse der zweiten klinischen Studie mit Pegfilgrastim Biosimilar-Kandidaten B12019.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 198
- Publication type:
- Article
4
Halaven<sup>®</sup> (Eribulin) erhält erneut Empfehlung mit höchster Evidenz nach Taxan und Anthrazyklin beim fortgeschrittenen HER2-negativen/HR-positiven Mammakarzinom.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 198
- Publication type:
- Article
5
Doppelplus-Empfehlung für Perjeta und Herceptin in der Neoadjuvanz: «Wir erreichen höhere Remissionsraten».
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 197
- By:
- Publication type:
- Article
6
‘PraxisUmfrage Tumorschmerz’ soll neue Erkenntnisse liefern.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 196
- Publication type:
- Article
7
Brustkrebsbehandlung: Weniger ist mehr.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 195
- Publication type:
- Article
8
Biosimilars in the Treatment of Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- Proceeding
9
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 184, doi. 10.1159/000477576
- By:
- Publication type:
- Article
10
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 172, doi. 10.1159/000477575
- By:
- Publication type:
- Article
11
Efficacy of Liposomal Cytarabine in the Treatment of Leptomeningeal Metastasis of Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
12
Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy – a Prospective Clinical Study.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 160, doi. 10.1159/000458433
- By:
- Publication type:
- Article
13
Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 152, doi. 10.1159/000478087
- By:
- Publication type:
- Article
14
Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine Therapy.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 146, doi. 10.1159/000477795
- By:
- Publication type:
- Article
15
Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 138, doi. 10.1159/000477956
- By:
- Publication type:
- Article
16
How to Achieve Optimal Care in Early Breast Cancer with ‘Less’ or ‘More’ Treatment.
- Published in:
- Breast Care, 2017, v. 12, n. 3, p. 136, doi. 10.1159/000478652
- By:
- Publication type:
- Article